Search form

You are here

Merck



Merck, Moderna detail potential skin cancer vaccine progress

  • The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients
  • “We are very excited, we are moving very quickly with Merck onto phase 3 for this study,” Moderna CEO Stephane Bancel
By AP ·

Britain approves Merck’s COVID-19 pill in world first

By Reuters ·

Latest updates

Atalanta beat 10-man Fiorentina 4-1 to reach Italian Cup final vs. Juventus
Mbappe stars in win over Lorient but PSG’s title party delayed by Monaco victory
Russia vetoes a UN resolution calling for the prevention of a dangerous nuclear arms race in space
Long-awaited US military aid no ‘silver bullet’ for Ukraine
Malala Yousafzai vows support for Gaza after backlash

Recommended

Middle-East
How Gaza conflict thrust Palestine statehood quest back to center stage
Saudi Arabia
How Saudi Arabia’s new economic cities can make manufacturing more sustainable
Middle-East
Have deaths of Quds Force commanders in Iran-Israel shadow war dented IRGC’s public image and confidence?

Search form

Print Edition
Read pdf version Subscribe now
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.